NCT07227337 Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study
| NCT ID | NCT07227337 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins University |
| Condition | Post Traumatic Stress Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 676 participants |
| Start Date | 2025-11-05 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 676 participants in total. It began in 2025-11-05 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to evaluate a trauma informed digital multicomponent intervention design to improve health and safety outcomes for women with lifetime exposures to violence and co-occurring PTSD and/or depression symptoms
Eligibility Criteria
Inclusion Criteria: * age 18 or older * foreign-born immigrant woman * self-reported history of cumulative exposure to violence, and presence of PTSD and/or depression symptoms Exclusion Criteria: * Participants who don't meet the above criteria
Contact & Investigator
Bushra Sabri
PRINCIPAL INVESTIGATOR
Johns Hopkins University
Frequently Asked Questions
Who can join the NCT07227337 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Post Traumatic Stress Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07227337 currently recruiting?
Yes, NCT07227337 is actively recruiting participants. Contact the research team at bsabri1@jhu.edu for enrollment information.
Where is the NCT07227337 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT07227337 clinical trial?
NCT07227337 is sponsored by Johns Hopkins University. The principal investigator is Bushra Sabri at Johns Hopkins University. The trial plans to enroll 676 participants.